Currently, there are 496.46M common shares owned by the public and among those 491.95M shares have been available to trade.
The company’s stock has a 5-day price change of 3.29% and 61.20% over the past three months. ELAN shares are trading 4.39% year to date (YTD), with the 12-month market performance up to 21.80% higher. It has a 12-month low price of $8.02 and touched a high of $15.78 over the same period. ELAN has an average intraday trading volume of 6.09 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 4.85%, 14.48%, and 20.78% respectively.
Institutional ownership of Elanco Animal Health Inc (NYSE: ELAN) shares accounts for 100.77% of the company’s 496.46M shares outstanding.
It has a market capitalization of $7.33B and a beta (3y monthly) value of 1.67. The stock’s trailing 12-month PE ratio is 19.69, while the earnings-per-share (ttm) stands at $0.75. The company has a PEG of 3.22 and a Quick Ratio of 1.46 with the debt-to-equity ratio at 0.69. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.44% over the week and 2.87% over the month.
Earnings per share for the fiscal year are expected to decrease by -7.58%, and 13.21% over the next financial year. EPS should shrink at an annualized rate of 6.11% over the next five years, compared to 29.95% over the past 5-year period.
UBS coverage for the Elanco Animal Health Inc (ELAN) stock in a research note released on December 09, 2024 offered a Buy rating with a price target of $18. Leerink Partners was of a view on December 02, 2024 that the stock is Market Perform, while Morgan Stanley gave the stock Equal-Weight rating on September 19, 2024, issuing a price target of $17- $15. Stifel on their part issued Buy rating on January 05, 2024.
